IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 26 filers reported holding IMMUCELL CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,960 | -50.0% | 6,000 | -50.5% | 0.00% | 0.0% |
Q2 2023 | $61,863 | +47.8% | 12,130 | +49.2% | 0.00% | 0.0% |
Q1 2023 | $41,870 | -15.8% | 8,130 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $49,756 | -18.4% | 8,130 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $61,000 | -14.1% | 8,130 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $71,000 | -9.0% | 8,130 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $78,000 | +20.0% | 8,130 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $65,000 | +261.1% | 8,130 | +306.5% | 0.00% | – |
Q3 2021 | $18,000 | -5.3% | 2,000 | 0.0% | 0.00% | – |
Q2 2021 | $19,000 | 0.0% | 2,000 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $19,000 | -84.4% | 2,000 | -90.2% | 0.00% | -66.7% |
Q4 2020 | $122,000 | -23.8% | 20,500 | -30.5% | 0.00% | -40.0% |
Q3 2020 | $160,000 | +15.1% | 29,500 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $139,000 | +43.3% | 29,500 | +15.7% | 0.01% | +25.0% |
Q1 2020 | $97,000 | -26.0% | 25,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $131,000 | -10.9% | 25,500 | -3.8% | 0.00% | -20.0% |
Q3 2019 | $147,000 | -20.5% | 26,500 | -7.0% | 0.01% | -28.6% |
Q2 2019 | $185,000 | -43.4% | 28,500 | -44.7% | 0.01% | -41.7% |
Q1 2019 | $327,000 | – | 51,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
Creative Planning | 310 | $1,000 | 0.00% |
Renaissance Technologies | 10,000 | $38,000 | 0.00% |
UBS AG | 1,870 | $7,000 | 0.00% |
US BANCORP \DE\ | 24 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
MORGAN STANLEY | 29,628 | $111,000 | 0.00% |